Daan G Knapen

5PUBLICATIONS
51CO-AUTHORS
Medical physicsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 08, 2026
Tri-specific Humabody CB307 Targeting CD137, Prostate-specific Membrane Antigen, and Human Serum Albumin Whole-body Biodistribution Measured with 89Zr-CB307 PET.

|Mar 17, 2025
A Phase I Dose Escalation and Cohort Expansion Study of CB307, a Trispecific Humabody against PSMA, CD137, and Albumin in Patients with PSMA-Positive Solid Tumors.

Johann S de Bono, Anja Williams, Ignacio Melero

|May 06, 2024
Lethal Capecitabine Toxicity in Patients With Complete Dihydropyrimidine Dehydrogenase Deficiency Due to Ultra-Rare DPYD Variants.

André B P van Kuilenburg, Marjolein C H Pleunis-van Empel, Rick B Brouwer

|May 03, 2024
Independent transcriptional patterns reveal biological processes associated with disease-free survival in early colorectal cancer.

Daan G Knapen, Sara Hone Lopez, Derk Jan A de Groot

|Apr 13, 2023
Potential, Limitations and Risks of Cannabis-Derived Products in Cancer Treatment.

Herman J Woerdenbag, Peter Olinga, Ellen A Kok

Pageof 1

Frequent Collaborators

3 joint publications

Elisabeth Ge de Vries

2 joint publications

Kenji Hashimoto

2 joint publications

Kevin Duffy

2 joint publications

Arkajyoti Bhattacharya